The Patent Finder

Terms ending in 2040

Codiak Biosciences, Inc.

Every in-force patent on Codiak Biosciences, Inc.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,992,527Extracellular Vesicles for Vaccine Delivery
In force
 · High confidence
Lonza Sales AGIn forceHigh confidence
US 12,502,427Extracellular Vesicles for Vaccine Delivery
In force
 · High confidence
Lonza Sales AGIn forceHigh confidence
US 12,766,110Extracellular Vesicles Comprising Sting-Agonist
In force
 · High confidence
Lonza Sales AGIn forceHigh confidence
US 12,465,875Process for Preparing Extracellular Vesicles
In force
 · High confidence
Lonza Sales AGIn forceHigh confidence
US 12,622,876Methods of Suppressing Delivery of Exosomes to Liver and Spleen
In force
 · High confidence
Lonza Sales AGIn forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Codiak Biosciences, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited